Genomes.io is a series b startup. 1 investor tracked.
Based in the United Kingdom, Genomes.io is a startup founded in 2025. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Genomes.io provides a platform for individuals to securely store and manage their genomic data, enabling them to control access and share segments of their genome with researchers for compensation while maintaining privacy.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.